Fuzzy role of hyperhomocysteinemia in hemodialysis patients' mortality.

Simic-Ogrizovic, S; Stosovic, M; Novakovic, I; Pejanovic, S; Jemcov, T; Radovic, M; Djukanovic, L

Simic-Ogrizovic, S; Stosovic, M; Novakovic, I; Pejanovic, S; Jemcov, T; Radovic, M; Djukanovic, L.

Affiliation

Simic-Ogrizovic S; Clinic of Nephrology, Institute of Urology and Nephrology, Clinical Center of Serbia, Pasterova 2, 11,000 Belgrade, Serbia and Montenegro. dst@eunet.yu

Biomed Pharmacother ; 60(4): 200-7, 2006 May.

Article in En | MEDLINE | ID: mdl-16647238

Subject(s)

Hyperhomocysteinemia/complications; Kidney Failure, Chronic/complications; Kidney Failure, Chronic/mortality; Renal Dialysis; Adult; Aged; Female; Follow-Up Studies; Homocysteine/blood; Humans; Kidney Failure, Chronic/therapy; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Renal Dialysis / Hyperhomocysteinemia / Kidney Failure, Chronic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biomed Pharmacother Year: 2006 Document type: Article Country of publication: France

Search on Google

Add to My VHL

XML

PubMed Links